Development of High-Specificity Fluorescent Probes to Enable Cannabinoid Type 2 Receptor Studies in Living Cells

Journal: Journal of the American Chemical Society

Published: 2020-09-09

DOI: 10.1021/jacs.0c05587

Affiliations: 21

Authors: 57

Go to article
Institutions Share
Roche Pharma Research and Early Development (Roche pRED), Switzerland 0.33
Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Germany 0.09
Laboratory of Organic Chemistry (LOC), ETH Zurich, Switzerland 0.07
Faculty of Experimental Sciences, UFV, Spain 0.07
Faculty of Medicine and Health Sciences, UoN, United Kingdom (UK) 0.06
Centre of Membrane Proteins and Receptors (COMPARE), United Kingdom (UK) 0.06
NIH National Institute on Alcohol Abuse and Alcoholism (NIAAA), United States of America (USA) 0.06
William Harvey Research Institute (WHRI), QMUL, United Kingdom (UK) 0.05
Department of Pharmacology and Clinical Pharmacology, The University of Auckland, New Zealand 0.04
Institute of Biochemistry and Molecular Medicine (IBMM), UniBE, Switzerland 0.04
Research Group in Molecular Physiology, Leiden University, Netherlands 0.04
Neuroscience Research Center (NRC), MCW, United States of America (USA) 0.03
IRCCS Santa Lucia Foundation, Italy 0.02
Department of Microbiology and Immunology, MCW, United States of America (USA) 0.01
Department of Medicine, MCW, United States of America (USA) 0.01
Department of Pharmacology and Toxicology, MCW, United States of America (USA) 0.01
Hungarian Centre of Excellence for Molecular Medicine (HCEMM), Hungary 0.01
Faculty of Veterinary Medicine, UniTE, Italy 0.01
Department of Biotechnological and Applied Clinical Sciences, UNIVAQ, Italy 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER